XW033RBIntroduction of Letetresgene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 11

New Technology›Anatomical Regions›Introduction
ICD-10-PCS XW033RB
CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.FacebookXLinkedInPrint

XW033RB is a billable ICD-10-PCS procedure code for Introduction of Letetresgene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 11. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

Code Identity

ICD-10-PCS Code
XW033RB
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Letetresgene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 11
Parent Code
XW0
Short Description
Introduce Letetresgene in Periph Vein, Perc, New Tech 11

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation0Introduction
4BodyPart3Peripheral Vein
5Approach3Percutaneous
6Device/Substance/TechnologyRLetetresgene Autoleucel
7QualifierBNew Technology Group 11

Code History

FY 2026New code, effective October 1, 2025.
Replaces previously assigned code(s):
  • XW033FA — Introduce Non-CAR-T Ther in Periph Vein, Perc, New Tech 10

Similar Procedure Codes

Questions About XW033RB

Is XW033RB a billable code?

Yes. XW033RB is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Letetresgene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 11 on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in XW033RB mean?

XW033RB breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 3 is the BodyPart (Peripheral Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character R is the Device/Substance/Technology (Letetresgene Autoleucel); the 7th character B is the Qualifier (New Technology Group 11).